Figure 1: The Structure of zoliflodacin   Introduction Zoliflodacin (Figure 1, above) is an orally administered DNA gyrase (topoisomerase) inhibitor, under study for the treatment of Gonorrhoea. The Global Antibiotics Research and Development Partnership (GARDP) recently announced that the primary endpoint for its phase 3 clinical trial (noninferiority to ceftriaxone/azithromycin) was met.1,2 In isolation,

Estimating the synthetic accessibility of molecules with building block and reaction-aware SAScore JCIM. 2024. ISSN: 1758-2946 The one question most chemists ask when viewing molecules generated using computational tools, machine-learning methods or AI models is but how easy is it to make? MedChemica users will know that we use Peter Ertl’s SAScore1 within CoreDesign to

Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators Med. Chem.2024, 67, 14432-14442   Coenzyme A (CoA) is a thiol cofactor that carries carboxylic acid substrates to where they are needed in important metabolic pathways, such as the Citric Acid Cycle. CoA is biosynthesised from pantothenic acid (Vitamin B5). The first and rate-limiting step of this

N‐Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors   J. Med. Chem.2024, 67, 13737-13764   Emerging pathogenic viruses of pandemic potential remain a global public health concern. In recent decades, outbreaks of 2 significant members of the Filovirus family (Filoviridae): Ebola virus (EBOV) and Marburg virus (MARV) have occurred, resulting in thousands of deaths in

Prediction of Inhibitory Activity against the MATE1 Transporter via Combined Fingerprint- and Physics-Based Machine Learning Models The multidrug and toxin extrusion transporter (MATE1) is located in the renal epithelial cells and mediates efflux of organic cations, like metformin. It is understood that clinical inhibitors of organic cation transporters may also inhibit MATE1, which causes concern

Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment Wei Long et al J. Med. Chem. 2024, 67, 13534−13549     This paper in the August addition has promoted a little bit of a SHP2 inhibitor profile – so more a suite of papers than a paper of the month... There are two